Skip to main content
Clinical Trials/CTRI/2014/08/004892
CTRI/2014/08/004892Completed未知

ASSESSMENT OF BLOOD MAGNESIUM LEVELS AND ITS OUTCOME IN NEONATES OF ECLAMPTIC MOTHERS TREATED WITH LOW DOSE MAGNESIUM SULPHATE REGIME

BURDWAN MEDICAL COLLEGE BURDWA0 sites100 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1. Eclampsia was diagnosed if there was h/o generalized tonic clonic convulsions with or without elevated blood pressure and proteinuria (by dipstick method) in the absence of any underlying seizure disorders after 20 wks of gestational age.
  • 2. All cases of antepartum, intrapartum eclampsia, presenting in obstetric emergency, labour rooms and/or wards who gave informed consent to participate in the study were included in the study.
  • 3. Neonates (of eclamptic mothers), of gestational age > 28 wks, were included in the study.

Exclusion Criteria

  • Eclampsia patients who had renal failure, severe pulmonary oedema with respiratory failure, having received magnesium sulphate and/or other anticonvulsant before coming to our hospital, cerebrovascular accident and Disseminated Intravascular Coagulation (DIC) were excluded from the from the present study. Neonates (of eclamptic mothers), of gestational age < 28 wks were excluded from the present study.

Investigators

Similar Trials

Condition of newborns of mothers with... | Clinical Trial